Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Diabetes / Metabolic Neurology Rheumatology Women's Health Mental Health / Psychiatry Dermatology Rare Diseases Men's Health
Clinical Trial ● Currently Recruiting NCT05819944

A Trial Evaluating Novel Technologies for the Diagnosis of Asthma The LUNG-TECH Trial

A Trial Evaluating Novel Technologies for the Diagnosis of Asthma The LUNG-TECH Trial — Recruiting • Respiratory / COPD / Asthma • NCT05819944.

📅 06 Jul 2026 ⏱ 2 min read
Currently Recruiting
This trial is actively seeking participants in the UK. Discuss eligibility with your patient before referring.
Status
Currently Recruiting
NCT ID
NCT05819944
Sponsor
Portsmouth Hospitals NHS Trust
Start
2023-01-09
ClinicaliQ Trial Snapshot
  • A Trial Evaluating Novel Technologies for the Diagnosis of Asthma The LUNG-TECH Trial — Recruiting • Respiratory / COPD / Asthma • NCT05819944.
  • Novel diagnostic technologies are being evaluated across three pathways to determine their clinical utility in asthma diagnosis, including their ability to differentiate asthma from health and other respiratory conditions, with the goal of generating evidence for NHS adoption into standard practice.
  • Patient eligibility encompasses adults with confirmed asthma, suspected asthma, and healthy control volunteers, allowing the trial to establish diagnostic accuracy, sensitivity, and specificity across different clinical presentations and disease states.
Use This Page For
  • Quick orientation before opening the registry record.
  • Checking recruitment status, phase and sponsor at a glance.
  • Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying

This trial aims to evaluate novel diagnostic technologies for asthma in 3 different pathways providing the necessary evidence-base to allow adoption into clinical practice: * Pathway 1 evaluates whether the technology can distinguish between people with asthma and healthy volunteers, and other respiratory conditions in a well characterised secondary-care population and whether the parameters they measure correlate with the current standard diagnostic tests; * Pathway 2 assesses whether the technology can accurately diagnose asthma (either independently or alongside current diagnostic tests) in a primary care population of patients where there…

Eligibility Snapshot
  • : * • Diagnosis confirmed by a specialist supported by any of the following within the last 5-years: i) Evidence of variable and/or reversible airflow obstruction * FEV1/FVC ratio 20 PYH (other than COPD and asthma with significant smoking history group) * The participant is unable to provide informed consent or is unable to complete the study procedures Healthy Volunteers: * No current clinical diagnosis of (or treatment for) a respiratory disease and no treatment for a respiratory tract Infection within the last 6 months * Never smoker or ex-smoker with ≤10 pack-years smoking history, and stopped smoking at least 6-months prior to enrolment * Non-obstructive spirometry

Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.

Full Trial Details
View this trial on the source registry
Eligibility criteria, protocol, and results when available
View Trial ↗
Share: Twitter/X LinkedIn
Related

Related Clinical Intelligence

Guidelines, Drug Science, safety briefs and education connected to this trial area.

Clinical Brief
Over one million children referred for mental healthcare – with anxiety the main reason
Respiratory / COPD / Asthma · BBC Health · 29 Jun 2026
Over one million children in England have been referred for mental healthcare, with anxiety as the leading presenting complaint, indicating a substantial…
View brief →
Guideline
UK Achondroplasia Network’s consensus guideline for multidisciplinary care of children and young people with achondroplasia: NICE review
Respiratory / COPD / Asthma · 19 May 2026
Establish multidisciplinary team review at diagnosis and at key developmental stages (infancy, pre-school, school age, adolescence) to monitor for complications including spinal…
View guideline →
Clinical Brief
There’s a reason child vaccination rates are falling – and it’s not social media
Respiratory / COPD / Asthma · BBC Health · 03 Aug 2026
Vaccination rates declining across UK: Child immunisation coverage is falling below safe thresholds needed for herd immunity, creating vulnerability to vaccine-preventable disease…
View brief →
Clinical Brief
Motherhood not all warm and fuzzy: Bollywood actor’s play spotlights messier side
Respiratory / COPD / Asthma · BBC Health · 09 Jul 2026
Maternal mental health and wellbeing deserve greater clinical recognition and discussion, as societal expectations often diminish the psychological burden of motherhood Healthcare…
View brief →
Clinical Brief
Amiodarone: reminder of risks of treatment and need for patient monitoring and supervision
Respiratory / COPD / Asthma · MHRA · 20 May 2026
Amiodarone carries serious risks of pulmonary, hepatic, and thyroid toxicity requiring regular patient monitoring and supervision throughout treatment Healthcare professionals must ensure…
View brief →
Clinical Brief
AI sleep data could provide one-week early warning of flu and COVID-19
Respiratory / COPD / Asthma · UKHSA · 03 Sep 2026
Sleep-tracking apps analysing cough patterns can detect flu and COVID-19 approximately one week before symptom onset, potentially enabling early intervention and isolation…
View brief →